Bruijstens AL, Blok KM, Smolders J, Wokke BH, et al. Pediatric MS patients with a primary progressive-like disease may still have
relevant inflammatory activity and may benefit from regular MS treatment. Mult Scler 2020 May 14:1352458520921367. doi: 10.1177/1352458520921367.
PMID: 32406801